Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pozza

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Tumori|October 31, 1983
Treatment of 49 unrandomized patients with advanced Hodgkin's diseaseT Chisesi, O Ricciardi, S Dal Fior, et al.
European Journal of Pharmacology|March 23, 1993
The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitroH R Olpe, M W Steinmann, T Ferrat, et al.
Chirurgia Italiana|June 1, 1988
[Small size breast cancer conservative surgical therapy and subsequent radiotherapy]F Zen, F Motteran, R Pigaiani, et al.
British Journal of Pharmacology|April 1, 1990
CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activityG E Fagg, H R Olpe, M F Pozza, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical studyG Gasparini, W J Gullick, S Maluta, et al.
Progress in Clinical and Biological Research|January 1, 1990
CGP 37849 and CGP 39551: novel competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activityG E Fagg, H R Olpe, M Schmutz, et al.
European Journal of Pharmacology|October 2, 1990
CGP 35348: a centrally active blocker of GABAB receptorsH R Olpe, G Karlsson, M F Pozza, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Tumori|October 31, 1983
Treatment of 49 unrandomized patients with advanced Hodgkin's diseaseT Chisesi, O Ricciardi, S Dal Fior, et al.
European Journal of Pharmacology|March 23, 1993
The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitroH R Olpe, M W Steinmann, T Ferrat, et al.
Chirurgia Italiana|June 1, 1988
[Small size breast cancer conservative surgical therapy and subsequent radiotherapy]F Zen, F Motteran, R Pigaiani, et al.
British Journal of Pharmacology|April 1, 1990
CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activityG E Fagg, H R Olpe, M F Pozza, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical studyG Gasparini, W J Gullick, S Maluta, et al.
Progress in Clinical and Biological Research|January 1, 1990
CGP 37849 and CGP 39551: novel competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activityG E Fagg, H R Olpe, M Schmutz, et al.
European Journal of Pharmacology|October 2, 1990
CGP 35348: a centrally active blocker of GABAB receptorsH R Olpe, G Karlsson, M F Pozza, et al.
Pageof 9